Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Inherited Erythromelalgia”

5 trials

Showing 5 of 5 results

Early research (Phase 1)Enrolling By InvitationNCT07262268
What this trial is testing

A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia

Who this might be right for
Familial Erythromelalgia
Biohaven Therapeutics Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT01090622
What this trial is testing

Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

Who this might be right for
Primary ErythromelalgiaInherited Erythromelalgia
Xenon Pharmaceuticals Inc. 4
Testing effectiveness (Phase 2)Study completedNCT02917187
What this trial is testing

A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Who this might be right for
Primary Inherited Erythromelalgia
Biogen 8
Testing effectiveness (Phase 2)Study completedNCT01769274
What this trial is testing

Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia

Who this might be right for
Inherited Erythromelalgia
Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT01486446
What this trial is testing

Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia

Who this might be right for
Primary ErythromelalgiaInherited Erythromelalgia
Xenon Pharmaceuticals Inc. 8

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation